Search Results - "Esfahani, Shiva Hadi"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Is Diminazene an Angiotensin-Converting Enzyme 2 (ACE2) Activator? Experimental Evidence and Implications by Esfahani, Shiva Hadi, Jayaraman, Srinidhi, Karamyan, Vardan T

    “…Antiprotozoal veterinary drug diminazene aceturate (DIZE) has been proposed to be an angiotensin-converting enzyme 2 (ACE2) activator. Since then, DIZE was…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Imidazole Bioisostere Activators of Endopeptidase Neurolysin with Enhanced Potency and Metabolic Stability by Rahman, Md. Shafikur, Hadi Esfahani, Shiva, Zhang, Yong, Queen, Aarfa, Aljarrah, Manar, Kandil, Haya, Baez, Andrew, Abbruscato, Thomas J., Karamyan, Vardan T., Trippier, Paul C.

    Published in ACS medicinal chemistry letters (11-04-2024)
    “…The peptidase neurolysin (Nln) has been validated as a potential target for developing therapeutics for ischemic stroke (IS). Overexpression of Nln in a mouse…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    In-Vivo and Ex-Vivo Brain Uptake Studies of Peptidomimetic Neurolysin Activators in Healthy and Stroke Animals by Nozohouri, Saeideh, Esfahani, Shiva Hadi, Noorani, Behnam, Patel, Dhaval, Villalba, Heidi, Ghanwatkar, Yashwardhan, Rahman, Md. Shafikur, Zhang, Yong, Bickel, Ulrich, Trippier, Paul C., Karamyan, Vardan T., Abbruscato, Thomas J.

    Published in Pharmaceutical research (01-07-2022)
    “…Purpose Neurolysin (Nln) is a peptidase that functions to preserve the brain following ischemic stroke by hydrolyzing various neuropeptides. Nln activation has…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Structure-activity relationship studies of functionalized aromatic peptidomimetics as neurolysin activators by Rahman, Md. Shafikur, Esfahani, Shiva Hadi, Nozohouri, Saeideh, Kumari, Shikha, Kocot, Joanna, Zhang, Yong, Abbruscato, Thomas J., Karamyan, Vardan T., Trippier, Paul C.

    Published in Bioorganic & medicinal chemistry letters (15-05-2022)
    “…[Display omitted] Modulating peptidase neurolysin (Nln) has been identified as a potential cerebroprotective target for the development of therapeutics for…”
    Get full text
    Journal Article
  10. 10